Loading organizations...
Loading organizations...
Bioresorbable scaffold technology for treating peripheral arterial disease.
R3 Vascular has raised $104.8M across 2 funding rounds.
R3 Vascular has raised $104.8M in total across 2 funding rounds.
R3 Vascular has raised $104.8M in total across 2 funding rounds.
R3 Vascular's investors include Mike Hurley, MD, MS, 415 Capital, HBM-MedFocus, Wexford Capital.
R3 Vascular has raised $104.8M across 2 funding rounds. Most recently, it raised $87.0M Series B in May 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| May 20, 2024 | $87.0M Series B | Mike Hurley, MD, MS | 415 Capital |
| Oct 8, 2020 | $17.8M Other Equity / Series A | 415 Capital | HBM-MedFocus, Wexford Capital |